Results 11 to 20 of about 213,511 (352)

Neurotensin receptors in pancreatic ductal carcinomas [PDF]

EJNMMI Research, 2015
Abstract Background The frequent expression of neurotensin receptors (NT-R) in primaries of pancreatic ductal carcinomas has triggered the development of radioactive neurotensin analogs for possible in vivo targeting of these tumors.
Körner Jachertz, Meike, Waser, Beatrice, Strobel, Oliver, Büchler, Markus, Reubi, Jean Claude   +4 more
openaire   +4 more sources

Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology, 2020
Purpose The purpose was to assess the predictive ability of computed tomography (CT)-based radiomics signature in differential diagnosis between pancreatic adenosquamous carcinoma (PASC) and pancreatic ductal adenocarcinoma (PDAC).
S. Ren, R. Zhao, Wenjing Cui, Wenli Qiu, Kai Guo, Yingying Cao, S. Duan, Zhongqiu Wang, Rong Chen   +8 more
semanticscholar   +1 more source

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

World Journal of Gastrointestinal Oncology, 2020
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases, with an average 5-year survival rate of less than 10%. Unfortunately, the majority of patients have unresectable, locally advanced, or metastatic disease at the time of diagnosis.
P. Sarantis, E. Koustas, A. Papadimitropoulou, A. Papavassiliou, M. Karamouzis   +4 more
semanticscholar   +1 more source

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

Journal of Nuclear Medicine, 2020
Visual Abstract Pancreatic ductal carcinoma (PDAC) is a highly lethal cancer, and early detection and accurate staging are critical to prolonging survival.
M. Röhrich, P. Naumann, F. Giesel, P. Choyke, F. Staudinger, A. Wefers, Dawn P. Liew, C. Kratochwil, H. Rathke, J. Liermann, K. Herfarth, D. Jäger, J. Debus, U. Haberkorn, Matthias Lang, S. Koerber   +15 more
semanticscholar   +1 more source

Adenosquamous carcinoma of the pancreas: A rare and aggressive variant of pancreatic cancer

Clinical Case Reports, 2022
Adenosquamous carcinoma of the pancreas is a rare and aggressive histological subtype of pancreatic adenocarcinoma, which accounts for 1% to 4% of the exocrine pancreatic malignancies.
Faten Limaiem, Mohamed Hajri, Leila Ben Farhat   +2 more
doaj   +1 more source

Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Gastroenterology, 2020
Although the estimated time for development of pancreatic ductal adenocarcinoma (PDA) is more than 20 years, PDAs are usually detected at late, metastatic stages.
P. Storz, H. Crawford
semanticscholar   +1 more source

Anaplastic (undifferentiated) carcinoma of pancreas, an uncommon variant: Diagnosed on endoscopic-guided fine needle aspiration

Indian Journal of Pathology and Microbiology, 2023
Anaplastic carcinoma of pancreas (ACP) are rare pancreatic neoplasms. They are well known to be associated with more aggressive tumor behavior and less favorable prognosis than usual pancreatic ductal adenocarcinoma.
Md Ali Osama, Pooja Bakshi, Kusum Verma
doaj   +1 more source

Role of magnetic resonance imaging in the detection and characterization of solid pancreatic nodules: an update [PDF]

, 2015
Pancreatic ductal adenocarcinoma is the most common malignant tumor of the pancreas. The remaining pancreatic tumors are a diverse group of pancreatic neoplasms that comprises cystic pancreatic neoplasms, endocrine tumors and other uncommon pancreatic ...
Ansari, Najwa Al, Buonocore, Valeria, Gigli, Silvia, Maccioni, Francesca, Ramalho, Miguel, Semelka, Richard C   +5 more
core   +1 more source

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease

Paediatrica Indonesiana, 2020
Pancreatic ductal adenocarcinoma (PDAC) is highly uncommon in patients < 20 years of age, at less than 0.1% of population.1 Pancreatic tumors in children and adolescents can develop from endocrine or exocrine cells.
Sutaryo Sutaryo, Scolastika Dita Kristian   +1 more
doaj   +1 more source

The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis

Cancer Imaging, 2018
BackgroundImaging findings for pancreatic neuroendocrine carcinoma (PNEC) and pancreatic ductal adenocarcinoma (PDAC) often overlap. The aim of this study was to demonstrate the value of computed tomography (CT) imaging features and texture analysis to ...
Chuangen Guo, Xiaoling Zhuge, Qidong Wang, W. Xiao, Zhonglan Wang, Zhongqiu Wang, Zhan Feng, Xiao Chen   +7 more
semanticscholar   +1 more source